American Journal of Transplantation最新文献

筛选
英文 中文
Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database. 移植时偶然发现的肺癌的预后影响:移植受者科学登记处和国家癌症数据库的联合研究。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-16 DOI: 10.1016/j.ajt.2024.11.014
Ryan Rebernick, Juan Diaz Martinez, Marc De Perrot, Marcelo Cypel, Shaf Keshavjee, Rishindra Mamidi Reddy, Elliot Wakeam
{"title":"Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database.","authors":"Ryan Rebernick, Juan Diaz Martinez, Marc De Perrot, Marcelo Cypel, Shaf Keshavjee, Rishindra Mamidi Reddy, Elliot Wakeam","doi":"10.1016/j.ajt.2024.11.014","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.014","url":null,"abstract":"<p><p>The implications of a lung malignancy in a lung transplant recipient are poorly understood. Here, we linked national transplant and cancer databases to determine how lung cancer impacted prognosis in lung transplant recipients with incidentally explanted lung cancers (IELCs). Records from the Scientific Registry of Transplant Recipients and National Cancer Database were linked to identify 186 patients who received a lung transplant and were subsequently diagnosed with lung cancer. These patients were determined to have IELC and were compared to control patients who received a lung transplant but were not diagnosed with IELC. Of the 186 patients, 144 had non-small cell lung cancer (NSCLC), 6 had small cell lung cancer, and 36 had a neuroendocrine cancer. Patients with stage I/II NSCLC or any stage neuroendocrine cancer had comparable overall survival and rates of cancer-related mortality compared to controls. Conversely, patients with stage III/IV NSCLC had worse overall survival, higher rates of cancer-related mortality, and infrequently received cancer-specific non-operative treatment. Taken together, stage I/II NSCLC and neuroendocrine cancers should be reconsidered as an absolute contraindication to transplant. Conversely, patients with stage III/IV NSCLC had worse outcomes, and strategies are needed to increase the use of adjuvant therapy.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplantation and bariatric surgery: is sleeve gastrectomy really the panacea? 肝移植和减肥手术:袖状胃切除术真的是灵丹妙药吗?
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-16 DOI: 10.1016/j.ajt.2024.11.017
Bruno Sensi, Tommaso Maria Manzia
{"title":"Liver transplantation and bariatric surgery: is sleeve gastrectomy really the panacea?","authors":"Bruno Sensi, Tommaso Maria Manzia","doi":"10.1016/j.ajt.2024.11.017","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.017","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel intravascular bioartificial pancreas device shows safety and islet functionality over thirty days in non-diabetic swine. 一种新型血管内生物人工胰腺装置在非糖尿病猪身上显示出三十天的安全性和胰岛功能。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-16 DOI: 10.1016/j.ajt.2024.11.012
Sara Photiadis, Quynh Mai, Gabriel Montanez, Christopher Nguyen, Thomas Kramer, Douglas Photiadis, Charles Sylvia, Taylor Spangler, Khanh Hoa Nguyen
{"title":"A novel intravascular bioartificial pancreas device shows safety and islet functionality over thirty days in non-diabetic swine.","authors":"Sara Photiadis, Quynh Mai, Gabriel Montanez, Christopher Nguyen, Thomas Kramer, Douglas Photiadis, Charles Sylvia, Taylor Spangler, Khanh Hoa Nguyen","doi":"10.1016/j.ajt.2024.11.012","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.012","url":null,"abstract":"<p><p>In this study using a discordant, xenogeneic, transplant model we demonstrate functionality and safety of the first stent-based bioartificial pancreas device implanted endovascularly into an artery, harnessing the high oxygen content in blood to support islet viability. The device is a self-expanding nitinol stent that is coated with a bilayer of polytetrafluorethylene (PTFE) that forms channels to hold islets embedded in hydrogel. We completed a one-month study in the non-diabetic swine model (N=3) to test the safety of the device and to assess islet functionality after device retrieval. The luminal diameter of the devices from three animals on day 0 and day 30 was 10.01 ± 0.408 mm and 10.05 ± 0.25 mm, respectively. The stimulation index of the control and eBAP devices explanted at day 30 were 3.35 ± 0.97 and 4.83 ±1.20, respectively, and the islets stained positively for insulin and glucagon after 30 days in-vivo. This pilot study shows that BAP implantation into a peripheral artery is safe and supports islet functionality over 30 days, providing groundwork for future work assessing in-vivo function of the device in diabetic swine.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Induction Therapy in Lung Transplantation. 诱导疗法在肺移植中的作用
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-15 DOI: 10.1016/j.ajt.2024.11.011
Samantha M Landino, James T Nawalaniec, Nicole Hays, Asishana A Osho, Brian C Keller, James S Allan, Shaf Keshavjee, Joren C Madsen, Ramsey Hachem
{"title":"The Role of Induction Therapy in Lung Transplantation.","authors":"Samantha M Landino, James T Nawalaniec, Nicole Hays, Asishana A Osho, Brian C Keller, James S Allan, Shaf Keshavjee, Joren C Madsen, Ramsey Hachem","doi":"10.1016/j.ajt.2024.11.011","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.011","url":null,"abstract":"<p><p>Induction immunosuppression in solid organ transplantation involves a short course of potent immunosuppression in the perioperative period, with the goal of preventing early acute rejection and delaying initiation or reducing the dose of calcineurin inhibitors to minimize kidney injury. The use of induction immunosuppression in lung transplantation has increased over time, with over 80% of adult lung transplant recipients receiving some form of induction therapy. Currently, more than 70% of lung transplant recipients receive induction with an IL-2 receptor antagonist, and basiliximab is the most used agent. Despite this now common practice, the evidence to support and guide induction immunosuppression following lung transplantation is limited, making the use of induction somewhat controversial. Here, we review the available literature addressing the use of induction immunosuppression in lung transplant recipients.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Modified Iliac Artery Stent Graft with Side Branch Extension Facilitating Kidney Transplant in Severe Aortoiliac Occlusive Disease. 具有侧支延伸功能的新型改良髂动脉支架移植物为严重主动脉髂闭塞症患者的肾移植提供便利
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-15 DOI: 10.1016/j.ajt.2024.11.015
Christopher R Jacobs, Santh Lanka, Young Erben, Jacob Clendenon, Yaman Alsabbagh, C Burcin Taner, Shennen Mao, Dana Perry, Houssam Farres
{"title":"Novel Modified Iliac Artery Stent Graft with Side Branch Extension Facilitating Kidney Transplant in Severe Aortoiliac Occlusive Disease.","authors":"Christopher R Jacobs, Santh Lanka, Young Erben, Jacob Clendenon, Yaman Alsabbagh, C Burcin Taner, Shennen Mao, Dana Perry, Houssam Farres","doi":"10.1016/j.ajt.2024.11.015","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.015","url":null,"abstract":"<p><p>Kidney Transplant is the preferred treatment for end-stage renal disease (ESRD) patients. However, a subset of otherwise eligible patients have severe iliac artery calcification that preclude them from receiving a kidney transplant. This report highlights the application of a physician-modified external iliac artery stent graft with a side branch extension (SBE) to facilitate successful kidney transplantation in a 69-year-old African American female who was otherwise ineligible for kidney transplant due to the presence of severe circumferential bilateral iliac artery calcification. Four months later, the patient received a kidney transplant and recovered without complications. Her duplex ultrasound (DUS) revealed patent vasculature to the kidney graft, she produced adequate urine output, and creatinine and glomerular filtration rate (GFR) normalized by discharge. This underscores the potential for stent graft with SBE as an option for patients who were traditionally ineligible for kidney transplantation due to the presence of severe aortoiliac calcification.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) infections for early recognition and effective treatment of KSHV-associated inflammatory cytokine syndrome (KICS) in solid organ transplant recipients. 对卡波济肉瘤疱疹病毒 (KSHV)/ 人类疱疹病毒-8 (HHV-8) 感染进行血清学筛查和分子监测,以便早期识别和有效治疗实体器官移植受者的 KSHV 相关炎症细胞因子综合征 (KICS)。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-15 DOI: 10.1016/j.ajt.2024.11.013
Alessandra Mularoni, Andrea Cona, Matteo Bulati, Rosalia Busà, Monica Miele, Francesca Timoneri, Mariangela Di Bella, Salvatore Castelbuono, Floriana Barbera, Daniele Di Carlo, Lorenzo Volpe, Alessia Gallo, Anna Maria de Luca, Giulia Coniglione, Francesca Todaro, Patrizia Barozzi, Giovanni Riva, Giada Pietrosi, Salvatore Gruttadauria, Alessandro Bertani, Patrizio Vitulo, Alessandra Fontana, Manlio Cipriani, Sergio Rizzo, Antonio Arcadipane, Angelo Luca, Malgorzata Mikulska, Pier Giulio Conaldi, Paolo Antonio Grossi, Mario Luppi
{"title":"Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) infections for early recognition and effective treatment of KSHV-associated inflammatory cytokine syndrome (KICS) in solid organ transplant recipients.","authors":"Alessandra Mularoni, Andrea Cona, Matteo Bulati, Rosalia Busà, Monica Miele, Francesca Timoneri, Mariangela Di Bella, Salvatore Castelbuono, Floriana Barbera, Daniele Di Carlo, Lorenzo Volpe, Alessia Gallo, Anna Maria de Luca, Giulia Coniglione, Francesca Todaro, Patrizia Barozzi, Giovanni Riva, Giada Pietrosi, Salvatore Gruttadauria, Alessandro Bertani, Patrizio Vitulo, Alessandra Fontana, Manlio Cipriani, Sergio Rizzo, Antonio Arcadipane, Angelo Luca, Malgorzata Mikulska, Pier Giulio Conaldi, Paolo Antonio Grossi, Mario Luppi","doi":"10.1016/j.ajt.2024.11.013","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.013","url":null,"abstract":"<p><p>Kaposi sarcoma herpesvirus/human herpesvirus-8 (HHV-8) neoplastic and non-neoplastic disease in solid organ transplant (SOT) recipients can be life-threatening. We evaluated the seroprevalence of HHV-8 infection among donors (D) and recipients (R), the incidence of HHV-8 transmission/reactivation, and the clinical characteristics, management, and outcomes of HHV-8-related diseases, including Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome (KICS), in consecutive SOT patients from 2011 to 2023. HHV-8 seroprevalence was 3.3% in 1349 donors and 8.4% in 1856 recipients screened (p<0.0001). Among the D+/R- group (n=49), 13 patients developed HHV-8-related diseases: 7 liver recipients had KICS, and 1 lung recipient had Kaposi sarcoma (KS) with subsequent KICS. Four KICS patients treated with rituximab survived, while the 3 patients not treated with rituximab died. Within the D-/R- group, out of 5 (0.3%) patients with non-donor-derived primary HHV-8 infection, 3 liver recipients developed KICS. In the R+ patients (n=155), 3 developed KS. In our cohort, 25/944 (2.6%) liver transplant recipients had a primary HHV-8 infection, and 10 of them (40%) developed KICS; 40% (4/10) of HHV-8 seropositive heart transplant recipients developed reactivation and 2 of them (50%) had fatal KS. Serologic screening and molecular surveillance of D+/R- patient groups facilitate early recognition and effective therapy of KICS.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generalizability of Kidney Transplant Data in Electronic Health Records - The Epic Cosmos Database versus the Scientific Registry of Transplant Recipients. 电子健康记录中肾移植数据的通用性--Epic Cosmos 数据库与移植受者科学登记处的对比。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-14 DOI: 10.1016/j.ajt.2024.11.008
Michal A Mankowski, Sunjae Bae, Alexandra T Strauss, Bonnie E Lonze, Babak J Orandi, Darren Stewart, Allan B Massie, Mara A McAdams-DeMarco, Eric K Oermann, Marlena Habal, Eduardo Iturrate, Sommer E Gentry, Dorry L Segev, David Axelrod
{"title":"Generalizability of Kidney Transplant Data in Electronic Health Records - The Epic Cosmos Database versus the Scientific Registry of Transplant Recipients.","authors":"Michal A Mankowski, Sunjae Bae, Alexandra T Strauss, Bonnie E Lonze, Babak J Orandi, Darren Stewart, Allan B Massie, Mara A McAdams-DeMarco, Eric K Oermann, Marlena Habal, Eduardo Iturrate, Sommer E Gentry, Dorry L Segev, David Axelrod","doi":"10.1016/j.ajt.2024.11.008","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.008","url":null,"abstract":"<p><p>Developing real-world evidence from electronic health records (EHR) is vital to advance kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR dataset, which includes 274 million unique individuals cared for in 238 U.S. health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69,418 KT recipients transplanted between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). Demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years post-transplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or healthcare claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-modal profiling of transplant rejection: Discerning the forest from the trees. 移植排斥反应的多模式分析:从树木中辨别森林
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-14 DOI: 10.1016/j.ajt.2024.11.007
Michael S Andrade, Anita S Chong
{"title":"Multi-modal profiling of transplant rejection: Discerning the forest from the trees.","authors":"Michael S Andrade, Anita S Chong","doi":"10.1016/j.ajt.2024.11.007","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.007","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use - Two Cruise Ships, November 2022-July 2024. 2022 年 11 月至 2024 年 7 月,两艘游轮发生两起与私人使用的室外热水浴缸有关的退伍军人病症疫情。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-13 DOI: 10.1016/j.ajt.2024.11.006
{"title":"Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use - Two Cruise Ships, November 2022-July 2024.","authors":"","doi":"10.1016/j.ajt.2024.11.006","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.006","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142637953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Honoring the Twenty-Year Anniversary of the First Face Transplant. 纪念首次面部移植二十周年。
IF 8.9 2区 医学
American Journal of Transplantation Pub Date : 2024-11-11 DOI: 10.1016/j.ajt.2024.11.010
Lara C Pullen
{"title":"Honoring the Twenty-Year Anniversary of the First Face Transplant.","authors":"Lara C Pullen","doi":"10.1016/j.ajt.2024.11.010","DOIUrl":"https://doi.org/10.1016/j.ajt.2024.11.010","url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142612939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信